H.R. 9672, Vaccine Compensation Expansion with Tax Increase. Quorum's AI analysis reads it as a trade-off: gains for some, costs for others.
H.R. 9672 · Mixed
What it does
This bill modernizes the federal Vaccine Injury Compensation Program by increasing compensation awards for vaccine-related deaths and injuries (from unspecified baseline to $600,000 each), expanding the program to cover COVID-19 vaccines, adding new vaccines to the injury compensation table, and…
The analysis names vaccine manufacturers (PFE, JNJ, BMY, GH, DVA) via excise tax revenue funding compensation program, — and 2 more groups — among the beneficiaries.
The trade-off
The $2.20 excise tax increase may be passed to consumers, raising vaccine prices and potentially reducing vaccination rates—especially among uninsured and low-income populations—which could undermine public health goals even as the bill expands injury compensation.
The analysis put a high warning level on this bill. Transparency scores 55%; no detached riders.
Who is behind it
Filed by Lloyd Doggett. Cosponsored by Lloyd Smucker.